<DOC>
	<DOCNO>NCT00065455</DOCNO>
	<brief_summary>Retinitis pigmentosa ( RP ) collective term group inherit retinal dystrophy major cause irreversible blindness . RP type occur approximately 1 3500 person United States ( 1 ) . Gene mutation responsible majority RP . To date , mutation identify 30 different gene link RP ( 2 ) . The visual prognosis RP poor , since gradual relentless visual field loss lead eventually degree blindness ( 3 ) . Although effective treatment RP identify , participant supplement daily oral dose 15,000 IU vitamin A palmitate show , average , slow rate deterioration retinal function intervention continue several year ( 4 ) . The purpose research determine whether administration high oral dos vitamin A acutely improve cone photoreceptor function RP participant measure electroretinography ( ERG ) . In interventional , non-randomized , prospective , pilot study , 5 participant receive daily oral dose 50,000 IU vitamin A palmitate 4 week , follow maintenance dose 15,000 IU daily subsequent 2 week . The primary efficacy outcome relative percentage change ERG response amplitude subsequent vitamin A supplementation . A secondary efficacy outcome relative percentage change implicit time pre- post- vitamin A supplementation , improvement specify short response implicit time . Other secondary outcome improvement visual field ( Humphery , 10-2 ; sum threshold ) . Safety outcomes include visual field , ETDRS visual acuity , intraocular pressure , serum vitamin A level liver function test .</brief_summary>
	<brief_title>Investigating Effect Vitamin A Supplementation Retinitis Pigmentosa</brief_title>
	<detailed_description>Retinitis pigmentosa ( RP ) collective term group inherit retinal dystrophy major cause irreversible blindness . RP type occur approximately 1 3500 person United States . Gene mutation responsible majority RP . To date , mutation identify 30 different gene link RP . The visual prognosis RP poor , since gradual relentless visual field loss lead eventually degree blindness . Although effective treatment RP identify , participant supplement daily oral dose 15,000 IU vitamin A palmitate show , average , slow rate deterioration retinal function intervention continue several year . The purpose research determine whether administration high oral dos vitamin A acutely improve cone photoreceptor function RP participant measure electroretinography ( ERG ) . In interventional , non-randomized , prospective , pilot study , 10 participant ( five RHO1 gene mutation five without mutation ) receive daily oral dose 50,000 IU vitamin A palmitate 4 week , follow maintenance dose 15,000 IU daily subsequent 2 week . The primary efficacy outcome relative percentage change ERG response amplitude subsequent vitamin A supplementation . A secondary efficacy outcome relative percentage change implicit time pre- post- vitamin A supplementation , improvement specify short response implicit time . Other secondary outcome improvement visual field ( Humphrey 10-2 ; sum threshold ) . Safety outcomes include visual field , ETDRS visual acuity , intraocular pressure , serum vitamin A level liver function test .</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>INCLUSION CRITERIA : All participant must meet follow criterion participate study . 1 . Men woman age 18 year age old . ( Children exclude since high incidence vitamin A toxicity pediatric population . ) 2 . Diagnoses typical RP genetic subtypes ( simplex , autosomal dominant , autosomal recessive , Xlinked ) , determine primarily abnormally reduce ERG rod response amplitudes relatively affected cone ERG amplitudes . 3 . Mutation RHO1 gene determine genotyping . 4 . Participants flicker ERG measure reliably ( standard flicker ERG amplitude great 2 microV ) . 5 . Willingness use contraception duration study . 6 . Understood sign consent . EXCLUSION CRITERIA : Participants follow condition exclude study . 1 . Participants syndromic RP ( i.e. , Ushers syndrome ) . 2 . Have abnormal liver function ( great ULN ALT , AST , Alkaline Phosphate , Total Bilirubin ) . 3 . Hematocrit great 1.5 x ULN 4 . Have abnormal kidney function ( great than1.5 mg/dL serum creatinine ) . 5 . Currently take great 15,000 IU/day vitamin A supplementation within 6 month first screen visit . 6 . Is pregnant lactating ( due evidence sugests excessive intake vitamin A could tertogenic human affect content breast milk ) . 7 . Currently take great 400 IU/day vitamin E supplementation within 6 month enrollment . 8 . Vitamin A serum level exceed 150 microg/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 6, 2009</verification_date>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Vitamin A</keyword>
	<keyword>ERG</keyword>
	<keyword>RP</keyword>
</DOC>